July 26, 2012
/PRNewswire/ -- Securities lawyers at
are investigating alleged violations of shareholder protection laws by officers and directors of Human Genome Sciences, Inc. (NASDAQ: HGSI) in connection with a buyout for
per share to GlaxoSmithKline PLC. Concerned HGSI investors are encouraged to contact attorney
at 877-583-2855 or
about their rights and remedies.
"Analysts have pegged the value of the company as high as
per share," Hamilton Lindley said. "Shareholders are owed the highest price reasonably available in a corporate buyout. Our potential shareholder claim seeks to ensure those fiduciary duties are enforced at the highest levels of the company."
Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. HGSI stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at
or 877-583-2855 with questions or concerns.
Hamilton Lindley Goldfarb LLP2501 N. Harwood, Ste. 1801
75201(877) 583-2855 Toll Free Telephone (214) 583-2233 Local Phone Number (214) 583-2234 Fax Number
SOURCE Goldfarb LLP